Joe Fitchett

Dr. Joe Fitchett is the Senior Adviser for Biotechnology at the Institut Pasteur de Dakar in Senegal.1 In this role, he is responsible for the IPD vaccine pipeline and oversees the strategy to launch new capabilities for developing and producing regionally-relevant countermeasures for epidemics.1 He is involved in several key projects, including:

1. Project sponsor for the technology transfer of the first measles/rubella vaccine to be produced in Africa1
2. Overseeing the IPD-CEPI partnering agreement for outbreak vaccines1
3. Helping establish the Advanced Vaccine Bioprocessing lab and the Grand Challenges Sénégal innovation fund1

Prior to his current position, Dr. Fitchett's experience includes:

• Medical Director at Global Access Dx (formerly Mologic) from October 2018 to September 20211
• Frank Knox Fellow at Harvard University from 2015 to 20211
• Program Officer for Global Policy & Advocacy at the Bill & Melinda Gates Foundation from 2016 to 20181

Dr. Fitchett has a background in public health and infectious disease epidemiology from Harvard, clinical medicine from Imperial and Kings, and immunology of infectious diseases from the London School of Hygiene & Tropical Medicine (LSHTM).1 He has been involved in various research projects, including the establishment of the TB Centre at LSHTM and work on the HIV self-testing Africa (STAR) initiative.1